Litigation Details for Novartis Pharmaceuticals Corporation v. Roxane Laboratories Inc. (D. Del. 2014)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Roxane Laboratories Inc. (D. Del. 2014)
Docket | ⤷ Sign Up | Date Filed | 2014-09-16 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 6,239,124; 6,455,518 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Roxane Laboratories Inc.
Details for Novartis Pharmaceuticals Corporation v. Roxane Laboratories Inc. (D. Del. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2014-09-16 | 1 | United States Letters Patent No. 6,239,124 (“the ‘124 patent”). The ‘124 patent was duly and legally …United States Letters Patent No. 5,665,772 (“the ‘772 patent”). The ‘772 patent was duly and legally …United States Letters Patent No. 6,004,973 (“the ‘973 patent”). The ‘973 patent was duly and legally …United States Letters Patent No. 6,455,518 (“the ‘518 patent”). The ‘518 patent was duly and legally …772, ‘973, ‘124, and ‘518 patents was an act of infringement of those patents. 32. | External link to document | |
2014-09-16 | 4 | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,665,772; 6,004,973; 6,239,124; 6,455,518…16 September 2014 1:14-cv-01196 830 Patent None District Court, D. Delaware | External link to document | |
2015-10-16 | 73 | Infringement Chart Concerning United States Patent Nos. 6,239,124 and 6,455,518 and (2) Plaintiffs Objections and…16 September 2014 1:14-cv-01196 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |